Tapan Kadia

Statistics

Publications

Citations

315

H-Index

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Tapan Kadia is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and acute myeloid leukemia treatment.

Publications per year

2011–2015

Publications

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Marina Konopleva, Peter F. Thall, Cecilia Arana Yi et al. · Haematologica · 2015 · 122 citations · Full text

Medicine, Oncology, Pharmacology +16

A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

H. Jean Khoury, Guillermo Garcia‐Manero, Gautam Borthakur et al. · Cancer · 2011 · 64 citations

Medicine, Oncology, Pharmacology +17

Ruxolitinib in combination with Lenalidomide as therapy for patients with myelofibrosis

Naval Daver, Jörge E. Cortes, Kate J. Newberry et al. · Haematologica · 2015 · 62 citations · Full text

Medicine, Hematology, Pharmacotherapy +10

Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia

Aziz Nazha, Jörge E. Cortes, S. Faderl et al. · Haematologica · 2012 · 50 citations · Full text

Medicine, Hematology, Oncology +13

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

A. Al-Kali, Sergej Konoplev, E. Lin et al. · Haematologica · 2011 · 17 citations · Full text

Medicine, Hematology, Pathology +15

1–5 of 5